ArticleNature genetics2026
The landscape of gene loss and missense variation across the mammalian tree informs on gene essentiality.
Article in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patterns of gene and sequence preservation across species provide insight into gene essentiality under natural selection. Here we developed two interspecies constraint metrics across 462 mammalian species: Gene Identity Score of Mammalian Orthologs (GISMO), which quantifies gene loss weighted by evolutionary distance to humans, and GISMO-mis, which measures missense constraint using the ratio of missense to synonymous variation across mammals. Both metrics are strongly correlated with human loss of function, missense and dosage constraint derived from large-scale sequencing studies, yet are largely independent of coding sequence length. GISMO and GISMO-mis identify essential genes missed by existing human-only metrics, particularly short genes. Genes in the most constrained deciles are enriched for rare variant associations in disorders linked to reduced fecundity, including schizophrenia, autism and neurodevelopmental disorders, and show strong enrichment for common variant heritability. These deciles also exhibit reduced copy number variation, consistent with dosage sensitivity. In addition, GISMO improves prioritization of recessive disease genes and captures signatures of homozygous selection across the mammalian tree. Taken together, GISMO and GISMO-mis leverage deep mammalian evolution to provide complementary, length-robust measures of gene essentiality that strengthen disease-gene prioritization and illuminate the selective forces shaping human biology.
Identifiers
42901987What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.